2011
DOI: 10.5155/eurjchem.2.4.433-440.400
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and evaluation of a set of bis(methoxycarbonylmethylthio) heteroquinones as CDC25B phosphatase inhibitors

Abstract: A set of new heteroquinone derivatives bearing two methoxycarbonylmethylthio groups on the benzoquinone ring were synthesized and evaluated for CDC25B phosphatase inhibitory activity. All compounds inhibited the enzyme with IC50 values in the micromolar range regardless of the size and heteroatoms constituting the heterocycle fused to the quinone ring. Moreover, these quinonoid-based compounds showed moderate antiproliferative activity toward two cancer cell lines (HeLa and MiaPaca-2). These results provide ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 35 publications
0
5
0
Order By: Relevance
“…The malonic acid derivative 12 did not show the expected rise of the activity with IC 50 value 10.7 ± 0.5 µM on Cdc25B and displayed moderate cytotoxicities against the HeLa cell line [32], whereas compound 13 exhibited IC 50 of 4.55 ± 0.16 µM toward Cdc25B and weak activity against HeLa cell lines [32]. Bis(methoxycarbonylmethylthio)heteroquinone analog of vitamin K 3 14 showed reasonable activity against Cdc25B with IC 50 of 1.17 ± 0.04 µM [33].…”
Section: Cdc25 Inhibitors Based On the Quinoid Structurementioning
confidence: 94%
See 1 more Smart Citation
“…The malonic acid derivative 12 did not show the expected rise of the activity with IC 50 value 10.7 ± 0.5 µM on Cdc25B and displayed moderate cytotoxicities against the HeLa cell line [32], whereas compound 13 exhibited IC 50 of 4.55 ± 0.16 µM toward Cdc25B and weak activity against HeLa cell lines [32]. Bis(methoxycarbonylmethylthio)heteroquinone analog of vitamin K 3 14 showed reasonable activity against Cdc25B with IC 50 of 1.17 ± 0.04 µM [33].…”
Section: Cdc25 Inhibitors Based On the Quinoid Structurementioning
confidence: 94%
“…Dimethyl 2,2 -((5,8-dioxo-5,8-dihydroquinoline-6,7-diyl)bis(sulfanediyl)) diacetate ( 27) showed IC 50 of 1.63 ± 0.21 µM on Cdc25B. In addition, 27 showed inhibition percent of 79 ± 0.9 and 77 ± 2.1% at 100 µM toward HeLa and MiaPaCa-2 cell lines, respectively, while at 10 µM it showed an inhibition of 13 ± 0.9 and 24 ± 15.4% against the same cell lines, respectively [33].…”
Section: Cdc25 Inhibitors Based On the Quinoid Structurementioning
confidence: 97%
“…Quinolinequinones have shown promise in possible anti-tumor, [1][2][3][4] anti-cancer, 5 anti-bacterial, 6 trypanocidal, 7 anti-tuberculosis, 8 anti-inflammatory, 9 anti-malarial agents, 10 and anti-fungal. 11 Scheme 1.…”
Section: Introductionmentioning
confidence: 99%
“…The formation of diquinonylamines (86) [40] and an amine substituted analog (88) [41] were reported while 2,3-dichloro-1,4-naphthoquinone (1) reacted with benzotriazole (89) and aliphatic or aromatic amines to give the corresponding 2-amino-3-(benzotriazol-1-yl)-1,4-naphthoquinones (90) [42].…”
Section: Introductionmentioning
confidence: 99%